Quantification of Clonal Circulating Plasma cells in Relapsed Multiple Myeloma

The presence of clonal circulating plasma cells (cPCs) remains a marker of high-risk disease in newly diagnosed multiple myeloma (MM) patients. However, its prognostic utility in MM patients with previously treated disease is unknown. We studied 647 consecutive patients with previously treated MM se...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Gonsalves, Wilson I, Morice, William G, Rajkumar, S. Vincent, Gupta, Vinay, Timm, Michael M, Dispenzieri, Angela, Buadi, Francis K, Lacy, Martha Q, Singh, Preet P, Kapoor, Prashant, Gertz, Morie A, Kumar, Shaji K
Format: Artigo
Idioma:Inglês
Publicat: 2014
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4211997/
https://ncbi.nlm.nih.gov/pubmed/25113422
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13067
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars